Basics Acrivon Therapeutics, Inc. IPO Date: November 15, 2022 Sector: Healthcare Industry: Biotech Market Cap: $34.8M Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 4.12% Avg Daily Range (30 D): $0.06 | 4.09% Avg Daily Range (90 D): $0.16 | 5.47% Institutional Daily Volume Avg Daily Volume: .15M Avg Daily Volume (30 D): .94M Avg Daily Volume (90 D): .42M Trade Size Avg Trade Size (Sh.): 111 Avg Trade Size (Sh.) (30 D): 206 Avg Trade Size (Sh.) (90 D): 183 Institutional Trades Total Inst.Trades: 19 Avg Inst. Trade: $2.35M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $.86M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.29M Avg Closing Trade (30 D): $.55M Avg Closing Trade (90 D): $.55M Avg Closing Volume: 265.96K     News Sep 14, 2024 @ 7:10 AM Acrivon Therapeutics Reports Positive Endometrial ... Source: N/A Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A Jul 5, 2024 @ 1:31 PM AstraZeneca's (AZN) Tagrisso Gets EU Nod for First... Source: N/A Jul 2, 2024 @ 4:12 PM SpringWorks (SWTX) Completes NDA Submission for Mi... Source: Zacks Equity Research Jul 2, 2024 @ 3:00 PM AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for ... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.51 $-.59 $-2.38 Diluted EPS $-.51 $-.59 $-2.38 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -19.68M $ -22.83M $ -80.56M Operating Income / Loss $ -21.66M $ -24.95M $ -89.2M Cost of Revenue $ $ $ Net Cash Flow $ -.66M $ -3.6M $ 3.59M PE Ratio